Envisia Therapeutics Report issue

For profit Phase 2
Founded: Morrisville NC United States (2013)
Status: No NME R&D (2013)

Organization Overview

First Clinical Trial
2015
NCT02371746
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2015

Timeline

NOW
  • Now

Active Ingredients

Drugs in Phase 2 Trials (2)

timolol (blocadren) (1 trial)

travoprost (travatan) (1 trial)

Indications

Experimental Indications (Clinical Trials, Phases 1-4)


 

Glaucoma (Phase 2)

Glaucoma, Open-Angle (Phase 2)

Hypertension (Phase 2)

Ocular Hypertension (Phase 2)

Overview

  • Highest Phase: Phase 2
  • # of Trials: 1
  • # of Trial APIs: 2